RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy.
Med
; 4(12): 863-874, 2023 Dec 08.
Article
en En
| MEDLINE
| ID: mdl-38070481
Emerging evidence suggests that local tumor radiotherapy reshapes the repertoire of circulating myeloid-derived suppressor cells (MDSCs) and leads to their infiltration into the tumor microenvironment, which poses a major obstacle for radiotherapy efficacy. Recent findings have identified RNA m6A modification at the nexus of both anti-tumor immunity and radiation response. Here, we examine the mechanisms by which this RNA modification modulates the immune milieu of the radiation-remodeled tumor microenvironment. We discuss potential therapeutic interventions targeting m6A machinery to improve radiotherapy response.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Células Supresoras de Origen Mieloide
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Med
Año:
2023
Tipo del documento:
Article
Pais de publicación:
Estados Unidos